Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2021.05.26
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2021.05.26
POLL RESULTS OF THE 2020 ANNUAL GENERAL MEETING
2021.05.06
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2021.05.06
RESIGNATION OF VICE CHAIRMAN AND EXECUTIVE DIRECTOR
2021.05.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2021.05.03
2020 Environmental, Social and Governance Report
2021.04.28
2021 First Quarterly Report
2021.04.22
Notification Letter and Request Form to Non-Registered Shareholder
2021.04.22
PROXY FORM FOR THE 2020 ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, MAY 26, ...
2021.04.22
NOTICE OF THE 2020 ANNUAL GENERAL MEETING
第一页
上一页
14
15
16
17
18
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
